CSL627_3001 Hemophilia A

Bleeding and Clotting Disorders


Condition or Disease: Hemophilia A

Study Type: Interventional (Clinical Trial)

Status: Open for enrollment

Study Title: A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII SingleChain, CSL627) in Subjects with Severe Hemophilia A

Principal I investigator: Joseph Lasky III, MD

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Explore More News